Verified Service Provider in Congo (Kinshasa)
Genomics Core Facilities in Congo (Kinshasa)
Engineering Excellence & Technical Support
Genomics Core Facilities solutions for Research & Discovery (R&D). High-standard technical execution following OEM protocols and local regulatory frameworks.
Advanced DNA Sequencing Capabilities
Our facility is equipped with cutting-edge next-generation sequencing (NGS) platforms, enabling high-throughput whole-genome, exome, and targeted sequencing. This allows for unparalleled genomic resolution in critical research areas such as infectious disease surveillance, agricultural improvement, and biodiversity studies within the Democratic Republic of Congo.
High-Resolution Sample Preparation & Quality Control
We employ robust protocols for DNA/RNA extraction, library preparation, and rigorous quality control using advanced bioanalyzer systems. This ensures the integrity and accuracy of genomic data, vital for reproducible research and reliable diagnostic applications in a challenging environment.
Scalable Bioinformatics & Data Analysis Infrastructure
Leveraging cloud-based and high-performance computing resources, we offer comprehensive bioinformatics services. This includes de novo assembly, variant calling, comparative genomics, and custom analysis pipelines, empowering researchers to extract meaningful insights from complex genomic datasets generated in the region.
What Is Genomics Core Facilities In Congo (Kinshasa)?
Genomics Core Facilities in Congo (Kinshasa) represent specialized laboratories equipped with advanced instrumentation and expertise to provide high-throughput genomic services. These facilities are designed to support a wide range of research and clinical applications by offering access to cutting-edge technologies for DNA/RNA sequencing, genotyping, epigenomic analysis, and other related molecular biology techniques. They function as a centralized resource, enabling researchers and institutions to conduct complex genomic studies without the need for individual investment in expensive equipment and specialized personnel.
| Who Needs Genomics Core Facilities? | Typical Use Cases | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Academic Research Institutions: Universities and research centers in Congo (Kinshasa) conducting basic, translational, and applied research in fields such as infectious diseases, agriculture, biodiversity, and human health. | Clinical Diagnostics Laboratories: Healthcare providers and diagnostic centers seeking to implement genomic-based diagnostics for inherited disorders, cancer profiling, infectious agent identification, and pharmacogenomics. | Public Health Agencies: Government and non-governmental organizations involved in disease surveillance, outbreak investigation, and public health policy development. | Agricultural and Environmental Sector: Researchers and organizations focused on crop improvement, livestock breeding, understanding microbial communities, and conservation genomics. | Biotechnology and Pharmaceutical Companies: Early-stage companies or R&D departments exploring new drug targets, developing diagnostics, or conducting preclinical studies. | Students and Trainees: Individuals pursuing advanced degrees or professional development in molecular biology, genetics, and bioinformatics. | Biodiversity and Conservation Projects: Researchers studying the genetic diversity of flora and fauna within the Democratic Republic of Congo for conservation efforts. | Genomic Epidemiology: Studying the genetic basis of disease transmission and resistance in populations. | Personalized Medicine Initiatives: Investigating individual genetic variations to tailor medical treatments and interventions. | Food Security and Agriculture: Identifying genetic markers for enhanced crop yield, disease resistance, and nutritional value in food crops and livestock. | Environmental Monitoring: Analyzing microbial communities in soil, water, and air to assess environmental health and impact. | Drug Discovery and Development: Identifying potential therapeutic targets and understanding drug response mechanisms. | Forensic Science: Investigating crime scenes through DNA analysis. | Population Genetics Studies: Understanding human migration patterns, genetic ancestry, and population structure within the region. |
Services Typically Offered by Genomics Core Facilities:
- Next-Generation Sequencing (NGS) Library Preparation and Sequencing (e.g., whole-genome, exome, transcriptome, amplicon sequencing)
- Genotyping services (e.g., SNP arrays, microsatellite analysis)
- Epigenomic analysis (e.g., ChIP-seq, ATAC-seq, bisulfite sequencing)
- Long-read sequencing technologies
- Bioinformatics support and data analysis pipelines
- Quality control of nucleic acids and libraries
- Consultation on experimental design and assay development
- Training and workshops on genomic technologies and methodologies
Who Needs Genomics Core Facilities In Congo (Kinshasa)?
Genomics core facilities in Congo (Kinshasa) are essential for advancing research, diagnostics, and public health initiatives. Their services cater to a diverse range of users, from academic institutions to healthcare providers and governmental organizations, all seeking to leverage the power of genomic information for specific goals.
| Customer Type | Key Needs | Example Applications |
|---|---|---|
| Academic/Research | High-throughput sequencing, genotyping, bioinformatics support | Biodiversity studies, understanding disease pathogenesis, crop improvement |
| Hospitals/Clinical Labs | Diagnostic sequencing (pathogens, inherited diseases), variant analysis | Identifying infectious agents, prenatal screening, cancer mutation profiling |
| Public Health Agencies | Outbreak surveillance, pathogen genomics, antimicrobial resistance tracking | Tracking Ebola outbreaks, monitoring malaria resistance, food safety testing |
| NGOs/International Orgs | Project-specific genomic analysis, capacity building | HIV/TB surveillance, conservation genetics, environmental DNA studies |
| Biotech/Pharma | Genomic screening, target validation, assay development | Identifying novel drug targets, developing rapid diagnostics |
Target Customers and Departments
- {"customer":"Academic and Research Institutions","departments":["Biology Departments","Biochemistry Departments","Genetics Departments","Medical Research Institutes","Public Health Schools","Veterinary Medicine Departments","Agricultural Research Centers"],"description":"These institutions are the primary drivers of fundamental scientific discovery and require advanced genomic technologies for projects ranging from understanding biodiversity and evolutionary biology to investigating disease mechanisms and developing novel therapeutic strategies."}
- {"customer":"Hospitals and Clinical Laboratories","departments":["Pathology Departments","Infectious Disease Units","Oncology Centers","Pediatric Departments","Maternity Wards","Clinical Genetics Services","Microbiology Laboratories"],"description":"For healthcare settings, genomics core facilities offer critical support for diagnostics, prognostics, and personalized medicine. This includes identifying causative agents of infectious diseases, detecting genetic predispositions to certain conditions, and guiding cancer treatment decisions."}
- {"customer":"Governmental and Public Health Agencies","departments":["National Public Health Institutes","Ministry of Health","Disease Surveillance Units","Epidemiology Departments","Food and Agriculture Organizations","Environmental Protection Agencies"],"description":"These agencies rely on genomic data for disease outbreak investigation, public health policy development, and monitoring of public health threats. They are key users for tracking pathogen evolution, identifying antimicrobial resistance, and assessing environmental impacts on health."}
- {"customer":"Non-Governmental Organizations (NGOs) and International Organizations","departments":["Health Programs","Research Collaborations","Humanitarian Aid Organizations","Disease Control Initiatives"],"description":"NGOs and international bodies involved in health, conservation, or development often partner with research institutions and require access to genomic expertise for their projects, particularly those focused on communicable diseases, genetic diversity, or environmental monitoring."}
- {"customer":"Biotechnology and Pharmaceutical Companies (Emerging)","departments":["Research and Development (R&D)","Drug Discovery","Diagnostics Development"],"description":"As the biotechnology sector grows in Congo, these companies will increasingly utilize genomics core facilities for early-stage research, drug target identification, and the development of novel diagnostic tools."}
Genomics Core Facilities Process In Congo (Kinshasa)
Genomics core facilities in Kinshasa, Democratic Republic of Congo, play a crucial role in advancing research and diagnostic capabilities. While specific workflows can vary between institutions, a general process from inquiry to execution typically involves several key stages. These stages ensure efficient project management, resource allocation, and high-quality data generation. The core facility acts as a central hub, offering expertise and advanced instrumentation that may not be readily available within individual research labs. This enables researchers to conduct complex genomic analyses, from basic sequencing to sophisticated multi-omics studies. The process is designed to be collaborative, with close communication between the core facility staff and the researchers throughout the project lifecycle.
| Stage | Description | Key Activities | Deliverables/Outputs |
|---|---|---|---|
| Initial Inquiry & Consultation | Researcher expresses interest and discusses project needs. | Email/request, meetings, feasibility assessment, initial scope definition. | Understanding of project goals, preliminary advice. |
| Project Proposal & Quote | Formalization of services, timelines, and costs. | Proposal writing, cost estimation, researcher review and approval. | Approved project proposal, cost quote. |
| Sample Submission & QC | Researchers submit samples, and the facility assesses their quality. | Sample tracking, DNA/RNA extraction, purity/integrity checks (e.g., Nanodrop, Bioanalyzer). | Accepted samples, QC reports. |
| Library Preparation | Preparing samples for sequencing. | Fragmentation, adapter ligation, amplification, library pooling. | Ready-to-sequence genomic libraries. |
| Sequencing | Generating raw sequence data. | Loading libraries onto sequencers, data acquisition. | Raw sequencing data (e.g., FASTQ files). |
| Data Processing & QC (Raw) | Initial assessment and cleaning of raw sequencing data. | Quality assessment (e.g., FastQC), adapter trimming, read filtering. | Quality-checked sequencing data. |
| Bioinformatics Analysis | Interpreting sequencing data. | Alignment, variant calling, gene expression analysis, statistical analysis. | Analyzed genomic data, identified biological insights. |
| Data Reporting & Delivery | Communicating findings to the researcher. | Report generation, visualization, data file compilation. | Comprehensive project report, final data files. |
| Project Closure & Feedback | Finalizing the project and gathering feedback. | Data delivery confirmation, feedback collection. | Project completion, service improvement insights. |
Genomics Core Facility Workflow: Inquiry to Execution
- Initial Inquiry and Consultation: Researchers interested in genomic services reach out to the core facility. This usually involves an email or a formal request outlining the project's scope, research question, and preliminary needs. A consultation meeting is then scheduled to discuss the project in detail. This is a critical step for understanding the scientific objectives, experimental design, sample types, and desired outcomes. The core facility team provides guidance on feasibility, recommended methodologies, potential challenges, and cost estimations. They assess if the project aligns with the facility's capabilities and available resources. Discussions may also cover data analysis expectations and timelines.
- Project Proposal and Quote Generation: Based on the consultation, the core facility develops a detailed project proposal. This document outlines the experimental plan, specific services to be provided (e.g., DNA/RNA extraction, library preparation, sequencing, bioinformatics analysis), estimated timelines, and a breakdown of costs. Researchers review and approve the proposal and quote. This stage often involves discussions and adjustments to refine the project scope and budget.
- Sample Submission and Quality Control: Once the project is approved, researchers prepare and submit their biological samples (e.g., tissue, blood, cells, DNA/RNA). Rigorous quality control (QC) is performed on incoming samples by the core facility. This may include assessing sample quantity, purity, integrity (e.g., using spectrophotometry, gel electrophoresis, or bioanalyzers). Samples failing QC may require re-submission or discussion with the researcher regarding potential impacts on downstream results.
- Library Preparation: The core facility's technical staff prepares genomic libraries from the submitted samples. This is a crucial step that converts the biological material into a format suitable for sequencing. The specific library preparation protocol depends on the type of analysis required (e.g., whole genome sequencing, exome sequencing, RNA-Seq, ChIP-Seq) and the sequencing platform being used. This often involves fragmentation of nucleic acids, adapter ligation, and amplification.
- Sequencing: The prepared libraries are loaded onto high-throughput sequencing instruments (e.g., Illumina sequencers). The instrument generates massive amounts of raw sequencing data, typically in FASTQ format. The choice of sequencing platform and read length is determined by the project requirements and budget.
- Data Processing and Quality Control (Raw Data): Raw sequencing data undergoes initial processing and quality control. This includes checking read quality scores, identifying and removing adapter sequences, and assessing overall sequencing metrics. Reads that do not meet quality thresholds may be trimmed or discarded. This stage ensures the integrity of the data before further analysis.
- Bioinformatics Analysis: This is a critical stage where raw sequencing data is transformed into biologically meaningful information. The core facility's bioinformatics team performs various analyses depending on the project's goals. This can include: aligning reads to a reference genome, variant calling (identifying genetic mutations), gene expression quantification, pathway analysis, de novo assembly, and more. Advanced statistical methods and computational tools are employed.
- Data Reporting and Delivery: The results of the bioinformatics analysis are compiled into a comprehensive report. This report typically includes key findings, visualizations (e.g., graphs, charts, heatmaps), tables of significant results, and interpretable genomic insights. The final data files are delivered to the researcher in agreed-upon formats. This may also involve a presentation or debriefing session to discuss the findings and their implications.
- Project Closure and Feedback: Once the data and reports are delivered, the project is considered closed. The core facility may solicit feedback from the researcher to improve their services and workflows. This iterative process of feedback is essential for continuous improvement and ensuring client satisfaction.
Genomics Core Facilities Cost In Congo (Kinshasa)
Genomics core facilities in Congo (Kinshasa) are still developing, and pricing can be highly variable due to several factors. Unlike established international centers, local facilities may have less standardized pricing structures, and costs can be influenced by the availability of reagents, expertise, and the specific research needs of the user. It's crucial for researchers to engage directly with available facilities for accurate quotes. General pricing discussions often revolve around the cost of specific services, with significant variations based on the technology used (e.g., Sanger sequencing vs. next-generation sequencing), the volume of samples, and the complexity of the analysis required. The local currency, the Congolese Franc (CDF), is used for most transactions, but international reagents and equipment often lead to pricing being influenced by USD equivalents. Emerging research institutions and universities may offer more subsidized rates for internal users, while private or external projects might incur higher costs.
| Service Type (Estimated Range) | Typical Price Range (Congolese Franc - CDF) | Notes |
|---|---|---|
| Sanger Sequencing (per reaction/fragment) | 50,000 - 250,000 CDF | Highly variable based on specific primer design and length of sequence. |
| NGS Library Preparation (per sample) | 200,000 - 1,500,000 CDF | Depends on the type of library (e.g., amplicon, whole-genome, RNA-Seq) and complexity of protocol. |
| NGS Sequencing (per lane, depending on output) | 1,500,000 - 10,000,000+ CDF | This is a very broad range. The cost is highly dependent on the sequencing platform, desired depth, and number of samples multiplexed per lane. |
| Basic Bioinformatics Analysis (e.g., QC, alignment) | 100,000 - 800,000 CDF | Can be per project or per sample. Advanced analysis will cost more. |
| Full Genome Sequencing (Human, Per Sample - estimate) | 10,000,000 - 50,000,000+ CDF | This would typically involve library prep and extensive sequencing. Often benchmarked against international prices in USD and then converted. |
Factors Influencing Genomics Core Facility Costs in Congo (Kinshasa):
- Type of Sequencing: Sanger sequencing is generally cheaper per base than next-generation sequencing (NGS) technologies like Illumina.
- Sequencing Depth and Read Length: Higher depth of coverage and longer reads for NGS increase computational and reagent costs.
- Sample Preparation: Complex library preparation protocols (e.g., for whole-genome sequencing, targeted sequencing, RNA-Seq) add to the overall expense.
- Number of Samples: Bulk discounts may be available for processing a large number of samples.
- Reagent and Consumable Costs: The availability and import costs of specialized reagents and consumables in the DRC significantly impact pricing.
- Equipment Maintenance and Calibration: The cost of maintaining and calibrating advanced sequencing and analysis equipment is factored in.
- Personnel Expertise and Training: Skilled personnel are required for running the equipment and performing data analysis, contributing to operational costs.
- Data Analysis and Bioinformatics Support: The level of bioinformatics support needed, from basic data processing to complex statistical analysis and interpretation, will affect the final price.
- Institutional Subsidies: Universities and research institutes may offer reduced rates for their affiliated researchers.
- Service Provider: Pricing can differ between academic core facilities, research collaborations, and potentially commercial service providers if they emerge.
- Urgency of Service: Rush orders may incur additional charges.
Affordable Genomics Core Facilities Options
Affordable genomics core facilities are crucial for researchers to access cutting-edge technologies without prohibitive costs. This involves understanding how core facilities structure their services and implementing smart strategies to maximize value and minimize expenses. Value bundles offer a way to package related services or access to specific equipment for a set price, often at a discount compared to individual service purchases. Cost-saving strategies range from proactive planning and efficient experimental design to leveraging shared resources and negotiating advantageous agreements.
| Strategy | Description | Potential Savings |
|---|---|---|
| Optimized Experimental Design | Careful planning to use only necessary samples and appropriate technologies. | Significant reduction in reagent, sequencing, and analysis costs. |
| Bulk Ordering/Project Aggregation | Combining orders or projects from multiple users to achieve volume discounts. | Lower per-sample costs through economies of scale. |
| Tiered Service Options | Choosing service levels that match project needs, avoiding over-speccing. | Paying only for the required level of service and support. |
| Staff Training & Consultation | Utilizing core facility staff expertise for experimental setup and troubleshooting. | Reduced trial-and-error, preventing costly failed experiments. |
| Institutional Agreements | Negotiated rates or subsidized services through institutional partnerships. | Potentially much lower per-service costs for affiliated researchers. |
| Grant Funding Application | Allocating funds from external grants specifically for core facility services. | Covers the direct costs of genomic services. |
Key Value Bundles and Cost-Saving Strategies
- Value Bundles Explained:
- Service Packages: Bundles often combine sample preparation, sequencing/genotyping, and basic data analysis for a specific type of experiment (e.g., whole-genome sequencing, targeted gene panels).
- Instrument Access Tiers: Some facilities offer tiered access to high-demand instruments, with higher tiers including more usage time or dedicated support.
- Project-Based Pricing: For larger, multi-faceted projects, core facilities might offer customized bundle pricing to encompass all necessary steps and resources.
- Training & Consultation Bundles: Bundles can include onboarding, training on specific instruments, and initial project consultation, making complex technologies more accessible.
- Cost-Saving Strategies:
- Efficient Experimental Design:
- Optimize sample number and minimize redundancy.- Choose the most cost-effective technology for the research question.- Plan data analysis early to avoid unnecessary sequencing depth or data generation.- Leverage Core Facility Resources Effectively:
- Understand pricing structures and choose the most economical options.- Inquire about discounts for bulk orders or recurring projects.- Take advantage of shared reagents and consumables when possible.- Utilize core facility staff expertise for troubleshooting and optimization.- Collaborative and Institutional Approaches:
- Collaborate with other labs to aggregate sample numbers and qualify for bulk discounts.- Explore institutional consortia or umbrella agreements with core facilities.- Advocate for institutional support to subsidize core facility services.- Proactive Planning and Communication:
- Discuss project scope and budget with core facility managers early on.- Understand turnaround times and plan experimental workflows accordingly.- Seek quotes for different service levels and options.- External Grants and Funding:
- Identify grant opportunities that can cover core facility costs.- Budget for core facility usage in grant proposals.
Verified Providers In Congo (Kinshasa)
Navigating healthcare in Congo (Kinshasa) can be challenging. For reliable and high-quality medical services, seeking out 'Verified Providers' is crucial. This ensures you are connecting with healthcare professionals and facilities that meet established standards for competence, safety, and ethical practice. Franance Health stands out as a premier organization for identifying and vetting such providers, offering peace of mind and a higher likelihood of positive health outcomes.
| Provider Type | Key Verification Aspects (Franance Health Focus) | Benefits for Patients |
|---|---|---|
| Hospitals & Clinics | Accreditation, licensing, medical equipment standards, hygiene protocols, staff qualifications, patient satisfaction scores. | Access to well-equipped facilities, adherence to safety standards, consistent quality of care, reduced risk of infection or malpractice. |
| Specialist Doctors | Medical board certifications, postgraduate qualifications, residency completion, peer reviews, ethical conduct checks, areas of specialization. | Expert diagnosis and treatment, access to specialized knowledge, confidence in the doctor's expertise, assurance of ethical practice. |
| General Practitioners | Licensing, continuous medical education, professional affiliations, patient feedback, commitment to primary care. | Reliable first point of contact for health concerns, trusted advice, effective management of common ailments, preventative care guidance. |
| Diagnostic Laboratories | Accreditation (e.g., ISO standards), quality control procedures, qualified technicians, equipment calibration, turnaround times for results. | Accurate and timely diagnostic results, reliable basis for treatment decisions, trust in laboratory integrity. |
| Pharmacies | Pharmacy board registration, licensed pharmacists, drug sourcing and storage protocols, dispensing accuracy, counterfeit drug prevention. | Access to genuine medications, safe dispensing practices, professional advice on prescriptions and over-the-counter drugs. |
Why Franance Health Credentials Matter
- Rigorous Vetting Process: Franance Health employs a comprehensive system to verify credentials, including academic qualifications, professional licenses, certifications, and a clean disciplinary record.
- Quality Assurance: Their verification process extends beyond basic credentials, often including assessments of practice standards, patient safety protocols, and adherence to ethical guidelines.
- Trust and Transparency: By clearly identifying Franance Health-verified providers, patients gain a trusted source of information, reducing the risk of encountering unqualified or fraudulent practitioners.
- Enhanced Patient Safety: The focus on verifying practices and adherence to standards directly contributes to a safer healthcare experience for patients.
- Access to Excellence: Franance Health helps pinpoint providers who demonstrate a commitment to ongoing professional development and maintaining high standards of care.
Scope Of Work For Genomics Core Facilities
This document outlines the Scope of Work for the Genomics Core Facilities, detailing technical deliverables and standard specifications. It serves as a comprehensive guide for researchers and facility staff, ensuring clarity, reproducibility, and quality in genomic services.
| Service Area | Standard Specification | Key Metrics | Deliverable Format |
|---|---|---|---|
| DNA Sequencing (Whole Genome/Exome) | Illumina NovaSeq 6000 / PacBio Sequel IIe / Oxford Nanopore PromethION | Read length, Q30 score, coverage depth, % mapped reads, variant call accuracy | FASTQ, BAM, VCF |
| RNA Sequencing (Bulk/Single-cell) | Illumina NovaSeq 6000 / 10x Genomics Chromium | Read length, Q30 score, % mapped reads, gene expression correlation, outlier detection | FASTQ, BAM, gene counts (TPM/FPKM/raw) |
| Genotyping Arrays | Illumina Infinium or equivalent | Call rate, heterozygosity rate, concordance with known genotypes | VCF, PLINK format |
| Epigenetic Sequencing (ChIP-seq, ATAC-seq, Bisulfite-seq) | Illumina NovaSeq 6000 | Peak calling sensitivity, signal-to-noise ratio, enrichment scores, methylation calling accuracy | BED, BAM, BigWig, VCF (for bisulfite) |
| Library Preparation | Standardized kits and protocols for Illumina/PacBio/ONT platforms | Library yield, insert size distribution, multiplexing efficiency | Library QC reports, pooled libraries |
| Bioinformatics Analysis | Standard pipelines (e.g., STAR, HISAT2, BWA, GATK, DESeq2, Seurat) | Workflow reproducibility, statistical significance of findings, QC of analysis outputs | Reports, figures, tables, annotated data files |
| Data Management & Storage | Secure, redundant storage with defined retention policies | Data integrity, accessibility, transfer speed | Access to raw and processed data via secure portal or LIMS |
Key Technical Deliverables
- High-quality raw sequencing data (FASTQ format)
- Trimmed and quality-filtered sequencing data
- Aligned sequencing data (BAM/SAM format)
- Variant calls (VCF format) with associated quality metrics
- Gene expression quantification (TPM, FPKM, or raw counts)
- De novo assembly reports (contigs, scaffolds, genome annotation)
- Metagenomic classification and abundance tables
- Epigenomic profiles (e.g., peak calls for ChIP-seq, methylation calls for bisulfite sequencing)
- Data QC reports for each stage of the workflow
- Standardized metadata and sample tracking information
- Accessible data storage and retrieval mechanisms
Service Level Agreement For Genomics Core Facilities
This Service Level Agreement (SLA) outlines the guaranteed response times and uptime for services provided by the Genomics Core Facilities. It aims to ensure reliable and timely access to essential genomic research resources for all users. This document applies to all core facility services, including sequencing, genotyping, bioinformatics support, and instrument access.
| Service Category | Response Time Guarantee (Business Hours) | Uptime Guarantee (%) | Notes/Exclusions |
|---|---|---|---|
| NGS Library Prep & Sequencing Inquiry | 24 Business Hours | 99.5% | Excludes external reagent/consumable lead times, complex project design consultation. |
| NGS Sequencing Run Completion | Variable (as per project quote) | 98.0% | Dependent on instrument availability, sample quality, and run complexity. Major instrument failures may impact this. |
| Sanger Sequencing Request Processing | 8 Business Hours | 99.0% | Assumes sample submission meets quality standards. |
| Genotyping Service Inquiry | 24 Business Hours | 99.5% | Excludes custom array design timelines. |
| Bioinformatics Support (Routine Queries) | 48 Business Hours | N/A (Support-based) | Complex analyses or custom scripting may require dedicated project consultation. |
| HPC Resource Access | Guaranteed access to allocated queues | 99.8% | Scheduled maintenance is excluded. Priority given to critical research projects. |
| Instrument Reservation System | Immediate confirmation | 99.9% | System downtime for essential maintenance. |
| General Core Facility Inquiry (Email/Phone) | 8 Business Hours | N/A (Operational) | For administrative or logistical questions. |
Key Service Areas Covered
- Next-Generation Sequencing (NGS) Library Preparation and Sequencing
- Sanger Sequencing
- Genotyping Services (e.g., SNP arrays, microsatellites)
- Single-Cell Genomics
- Bioinformatics Analysis and Data Management
- Access to High-Performance Computing (HPC) Resources
- Instrument Reservation and Usage
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Genomics Core Facilities in Congo (Kinshasa) project in Congo (Kinshasa).
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.